161 related articles for article (PubMed ID: 19940420)
1. Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults.
Rehm SJ; Farley MM; File TM; Hall WJ; Hopkins R; Levine OS; Nichol KL; Nuorti P; Zimmerman RK; Schaffner W
Postgrad Med; 2009 Nov; 121(6):101-5. PubMed ID: 19940420
[TBL] [Abstract][Full Text] [Related]
2. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
[TBL] [Abstract][Full Text] [Related]
3. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).
;
MMWR Morb Mortal Wkly Rep; 2010 Sep; 59(34):1102-6. PubMed ID: 20814406
[TBL] [Abstract][Full Text] [Related]
4. Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system.
Chi RC; Reiber GE; Neuzil KM
J Am Geriatr Soc; 2006 Feb; 54(2):217-23. PubMed ID: 16460371
[TBL] [Abstract][Full Text] [Related]
5. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age > or = 65.
Whitney CG
Geriatrics; 2003 Oct; 58(10):20-2, 25. PubMed ID: 14569639
[TBL] [Abstract][Full Text] [Related]
6. Increasing pneumococcal vaccination rates among patients of a National Health-Care Alliance--United States, 1993.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1995 Oct; 44(40):741-4. PubMed ID: 7565554
[TBL] [Abstract][Full Text] [Related]
7. Identifying barriers to adult pneumococcal vaccination: an NFID task force meeting.
Rehm SJ; File TM; Metersky M; Nichol KL; Schaffner W;
Postgrad Med; 2012 May; 124(3):71-9. PubMed ID: 22691901
[TBL] [Abstract][Full Text] [Related]
8. Influenza and pneumococcal vaccination coverage levels among persons aged > or = 65 years--United States, 1973-1993.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1995 Jul; 44(27):506-7, 513-5. PubMed ID: 7596336
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal and influenza vaccination levels among adults aged > or = 65 years--United States, 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Oct; 46(39):913-9. PubMed ID: 9347904
[TBL] [Abstract][Full Text] [Related]
10. Missed opportunities for pneumococcal and influenza vaccination of Medicare pneumonia inpatients--12 western states, 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Oct; 46(39):919-23. PubMed ID: 9347905
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal and influenza vaccination levels among adults aged > or = 65 years--United States, 1993.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Oct; 45(40):853-9. PubMed ID: 8927004
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal vaccines: World Health Organization position paper.
Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
[TBL] [Abstract][Full Text] [Related]
13. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
14. Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years--United States, 2004-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(39):1065-8. PubMed ID: 17021591
[TBL] [Abstract][Full Text] [Related]
15. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
[TBL] [Abstract][Full Text] [Related]
16. Influenza and pneumococcal vaccination levels among adults aged > or =65 years--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(38):797-802. PubMed ID: 9776166
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal bacteremia in Hawaii: initial findings of a pneumococcal disease prevention project.
Campbell JF; Donohue MA; Mochizuki RB; Nevin-Woods CL; Spika JS
Hawaii Med J; 1989 Dec; 48(12):513-4, 517-8. PubMed ID: 2635176
[TBL] [Abstract][Full Text] [Related]
18. Public health and aging: influenza vaccination coverage among adults aged > or =50 years and pneumococcal vaccination coverage among adults aged > or =65 years--United States, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Oct; 52(41):987-92. PubMed ID: 14561957
[TBL] [Abstract][Full Text] [Related]
19. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
Ridda I; Lindley IR; Gao Z; McIntyre P; Macintyre CR
Vaccine; 2008 Oct; 26(44):5633-40. PubMed ID: 18706955
[TBL] [Abstract][Full Text] [Related]
20. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(38):1071-4. PubMed ID: 19798021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
